Search results
Added:
6 months ago
TCT Middle East 2025 — We are joined by Prof Rania Hammami and Dr Uthman Aluthman as they discuss the key takeaways for minimally invasive surgery from the conference.The specialists provide insights on evolving definitions and expanding applications of minimally invasive cardiac surgical techniques. They address practical considerations regarding patient selection, recovery trajectories, and…
View more
Added:
4 weeks ago
Added:
1 year ago
Added:
2 months ago
Source:
Transcatheter Academy
While clinical trials typically report average health outcomes at specific time points, a new secondary analysis of the ISCHEMIA trial has delved into the individual patient journeys of angina symptoms over time. The study identified six distinct patterns of angina trajectories, revealing that an initial invasive strategy is associated with more favourable symptom pathways compared to a…
View more
Added:
2 weeks ago
Source:
Radcliffe Cardiology
Long-term data from the PARTNER 3 trial show no significant differences in key clinical outcomes at 7 years between transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement (SAVR) for low-risk patients with severe, symptomatic aortic stenosis.¹ This extended follow-up provides crucial insights into the durability and long-term safety of both procedures in this patient…
View more
Added:
1 year ago
Interventional Cardiology 2025;20:e03.
View more
Metabolic Surgery Superior to GLP-1 RAs for Long-Term Outcomes in Patients with Diabetes and Obesity
Added:
1 month ago
Source:
Radcliffe CVRM
News
Added:
2 months ago
Source:
Transcatheter Academy
For patients with symptomatic left-sided mechanical prosthetic valve thrombosis (PVT), the optimal treatment strategy between urgent surgery and fibrinolytic therapy (FT) has been uncertain. The SAFE-PVT trial, the first randomised controlled trial (RCT) to directly compare these approaches, found that while surgery is associated with a higher risk of complications and death, FT often results in…
View more
Added:
1 year ago
TCT Conference 2024 - Clinical outcomes between percutaneous mitral valve repair (PMVR) and mitral valve surgery in patients with atrial mitral regurgitation (MR).Dr Stephan Baldus (University of Köln Medical Center, DE) joins us onsite at TCT Conference to discuss the findings from MATTERHORN (NCT02371512; University of Köln).MATTERHORN is a multicenter, randomized controlled clinical trial,…
View more
Added:
1 year ago
ESC Congress 2024 — TEER non-inferior to mitral valve surgery with regard to death, HF rehospitalisation, stroke, reintervention of LVAD at one year.Dr Volker Rudolph (Heart and Diabetes Center NRW, DE) and Prof Stephan Baldus (University Hospital of Köln, DE) joins us in London to discuss the MATTERHORN trial (NCT02371512; University Hospital of Köln).This multicenter, randomized controlled…
View more